Researchers delve into the genomes of Staphylococcus capitis isolates prevalent in neonates, revealing transmission patterns and survival tactics of the NRCS-A strain in neonatal ICUs.
Biohaven’s troriluzole rejected before FDA review
Biohaven said Thursday it received a refusal-to-file letter from the FDA over its NDA for troriluzole in an announcement that sent its share price down